All Phenotypes Tcf3<+> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Tcf3⁺
wild type
MGI:2432259

Summary

15 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
ht1	\Tcf3^tm1Cmu/\Tcf3⁺	either: 129P2/OlaHsd-Tcf3^tm1Cmu or (involves: 129P2/OlaHsd * FVB/N)	MGI:3776820
ht2	\Tcf3^tm1Wein/\Tcf3⁺	either: (involves: 129/Sv * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J)	MGI:2680064
ht3	\Tcf3^tm1.1Mbu/\Tcf3⁺	involves: 129P2/OlaHsd * C57BL/6	MGI:3804185
ht4	\Tcf3^{tm1(TCF3/HLF)Homy}/\Tcf3⁺	involves: 129P2/OlaHsd * C57BL/6	MGI:4458208
ht5	\Tcf3^tm1Wein/\Tcf3⁺	involves: 129S4/SvJaeSor	MGI:3046427
cn6	\Pax5^tm3Mbu/\Pax5⁺ \Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Cd19^tm1(cre)Cgn/\Cd19⁺	involves: 129P2/OlaHsd * C57BL/6	MGI:5825360
cn7	\Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Cd19^tm1(cre)Cgn/\Cd19⁺	involves: 129P2/OlaHsd * C57BL/6	MGI:5825356
cn8	\Tcf3^{tm1(TCF3/HLF)Homy}/\Tcf3⁺ \Tg(Emu-Zfp521)1Homy/0 \Tg(Mx1-cre)1Cgn/0	involves: 129P2/OlaHsd * C57BL/6 * CBA	MGI:4458210
cn9	\Tcf3^{tm1(TCF3/HLF)Homy}/\Tcf3⁺ \Tg(Mx1-cre)1Cgn/0	involves: 129P2/OlaHsd * C57BL/6 * CBA	MGI:4458207
cn10	\Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Cd79a^tm1(cre)Reth/\Cd79a⁺	involves: BALB/c * C57BL/6	MGI:5825357
cn11	\Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Tg(Mx1-cre)1Cgn/0	involves: C57BL/6 * C57BL/6J * CBA/J	MGI:5825359
cx12	\Tcf4^tm1Zhu/\Tcf4⁺ \Tcf3^tm1Wein/\Tcf3⁺	involves: 129P2/OlaHsd	MGI:3040600
cx13	\Tcf4^tm1Zhu/\Tcf4⁺ \Tcf3^tm1Zhu/\Tcf3⁺	involves: 129P2/OlaHsd	MGI:3776854
cx14	\Id2^tm1Yyk/\Id2^tm1Yyk \Tcf3^tm1Cmu/\Tcf3⁺	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ	MGI:3776818
cx15	\Tcf12^tm1Zhu/\Tcf12⁺ \Tcf3^tm1Wein/\Tcf3⁺	involves: 129S4/SvJaeSor	MGI:3040599

Allelic Composition	\Tcf3^tm1Cmu/\Tcf3⁺
Genetic Background	either: 129P2/OlaHsd-Tcf3^tm1Cmu or (involves: 129P2/OlaHsd * FVB/N)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^tm1Cmu mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

decreased B cell number ( J:67011 )

• B220+IgM B cells are reduced to 58% compared to 64% in wild-type mice

hematopoietic system

decreased B cell number ( J:67011 )

• B220+IgM B cells are reduced to 58% compared to 64% in wild-type mice

Allelic Composition	\Tcf3^tm1Wein/\Tcf3⁺
Genetic Background	either: (involves: 129/Sv * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^tm1Wein mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

decreased B cell number ( J:22134 )

• B cell numbers reduced by half in the spleen but not the bone marrow

immune system

decreased B cell number ( J:22134 )

• B cell numbers reduced by half in the spleen but not the bone marrow

Allelic Composition	\Tcf3^tm1.1Mbu/\Tcf3⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^tm1.1Mbu mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

abnormal B cell differentiation ( J:137719 )

• mice exhibit a mild defect in adult B cell lymphopoiesis

immune system

abnormal B cell differentiation ( J:137719 )

• mice exhibit a mild defect in adult B cell lymphopoiesis

Allelic Composition	\Tcf3^{tm1(TCF3/HLF)Homy}/\Tcf3⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^{tm1(TCF3/HLF)Homy} mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:160392 )

N	• mice have a normal lifespan

hematopoietic system

hematopoietic system phenotype ( J:160392 )

N	• mice exhibit no abnormalities in peripheral blood

Allelic Composition	\Tcf3^tm1Wein/\Tcf3⁺
Genetic Background	involves: 129S4/SvJaeSor

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^tm1Wein mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

abnormal B cell number ( J:91042 )

• the IgM⁺IgD^- cell population is significantly reduced

• the IgM⁺IgD⁺ cell population is increased in the bone marrow

• the fraction of B cells expressing Ig-lambda is reduced

decreased pre-B cell number ( J:91042 )

• the fraction of pre-B cells is reduced about 2 fold

immune system

abnormal B cell number ( J:91042 )

• the IgM⁺IgD^- cell population is significantly reduced

• the IgM⁺IgD⁺ cell population is increased in the bone marrow

• the fraction of B cells expressing Ig-lambda is reduced

decreased pre-B cell number ( J:91042 )

• the fraction of pre-B cells is reduced about 2 fold

Allelic Composition	\Pax5^tm3Mbu/\Pax5⁺ \Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Cd19^tm1(cre)Cgn/\Cd19⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19^tm1(cre)Cgn mutation (12 available); any Cd19 mutation (61 available)
Pax5^tm3Mbu mutation (1 available); any Pax5 mutation (39 available)
Tcf3^tm1(PBX1)Mlc mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased B cell acute lymphoblastic leukemia incidence ( J:226241 )

• mice exhibit increased penetrance and accelerated acute leukemia development compared to single Tcf3^tm1(PBX1)Mlc conditional mutants

hematopoietic system

decreased immature B cell number ( J:226241 )

• preleukemic mice show a greater decrease of immature B cells of the Lin-CD19+CD43- fractions compared to Tcf3^tm1(PBX1)Mlc conditional mutants, indicating a more severe block of B cell differentiation at this stage of maturation

abnormal pro-B cell morphology ( J:226241 )

• preleukemic mice show expansion of GFP+ progenitor cells of the Lin-CD19+CD43+ fractions at younger ages compared to single Tcf3^tm1(PBX1)Mlc conditional mutants, indicating accelerated preleukemic progenitor B cell expansion

arrested B cell differentiation ( J:226241 )

immune system

decreased immature B cell number ( J:226241 )

abnormal pro-B cell morphology ( J:226241 )

arrested B cell differentiation ( J:226241 )

Allelic Composition	\Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Cd19^tm1(cre)Cgn/\Cd19⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19^tm1(cre)Cgn mutation (12 available); any Cd19 mutation (61 available)
Tcf3^tm1(PBX1)Mlc mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased B cell acute lymphoblastic leukemia incidence ( J:226241 )

• mice develop acute leukemia with an incidence of 7% at 12 months of age

• leukemia cells are present in the bone marrow, spleen, lymph nodes and infiltrate multiple organs, including the CNS

• 94% of leukemias have a B cell precursor phenotype

hematopoietic system

enlarged spleen ( J:226241 )

• in leukemic mice

abnormal pro-B cell morphology ( J:226241 )

• progenitor B cells proliferate extensively in methylcellulose culture supplemented with IL-7, SCF, and FLT3 and are severely compromised in the their ability to differentiate into CD43- cells compared with progenitor B cells from controls indicating enhanced proliferation of progenitor B cells

abnormal pro-B cell differentiation ( J:226241 )

• mice show perturbed early B cell progenitor cell differentiation

arrested B cell differentiation ( J:226241 )

• leukemic blasts are arrested at the pro/pre-B stage of B cell precursor differentiation

anemia ( J:226241 )

• in leukemic mice

thrombocytopenia ( J:226241 )

• in leukemic mice

decreased B cell number ( J:226241 )

• a lower percentage of B cells are seen in the peripheral blood over a 30 week period in healthy preleukemic mice

decreased immature B cell number ( J:226241 )

• decrease in immature and recirculating B cells in the bone marrow in healthy preleukemic mice

increased leukocyte cell number ( J:226241 )

• leukemic mice present with leukocytosis

abnormal B cell physiology ( J:226241 )

• enhanced proliferation of progenitor B cells

• preleukemic mice irradiated sublethally to deplete the endogenous B cell populations show regeneration of B cell progenitors with a dramatic expansion of B220^lo progenitor cell population indicating enhanced B cell progenitor self-renewal

immune system

enlarged spleen ( J:226241 )

• in leukemic mice

abnormal pro-B cell morphology ( J:226241 )

abnormal pro-B cell differentiation ( J:226241 )

• mice show perturbed early B cell progenitor cell differentiation

arrested B cell differentiation ( J:226241 )

• leukemic blasts are arrested at the pro/pre-B stage of B cell precursor differentiation

decreased B cell number ( J:226241 )

• a lower percentage of B cells are seen in the peripheral blood over a 30 week period in healthy preleukemic mice

decreased immature B cell number ( J:226241 )

• decrease in immature and recirculating B cells in the bone marrow in healthy preleukemic mice

increased leukocyte cell number ( J:226241 )

• leukemic mice present with leukocytosis

abnormal B cell physiology ( J:226241 )

• enhanced proliferation of progenitor B cells

enlarged lymph nodes ( J:226241 )

• in leukemic mice

liver/biliary system

enlarged liver ( J:226241 )

• in leukemic mice

growth/size/body

enlarged liver ( J:226241 )

• in leukemic mice

enlarged spleen ( J:226241 )

• in leukemic mice

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
acute lymphoblastic leukemia		DOID:9952	OMIM:247640 OMIM:613065	J:226241

Allelic Composition	\Tcf3^{tm1(TCF3/HLF)Homy}/\Tcf3⁺ \Tg(Emu-Zfp521)1Homy/0 \Tg(Mx1-cre)1Cgn/0
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^{tm1(TCF3/HLF)Homy} mutation (0 available); any Tcf3 mutation (48 available)
Tg(Emu-Zfp521)1Homy mutation (1 available)
Tg(Mx1-cre)1Cgn mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:160392 )

• within 6 months, pIpC-treated mice die of leukemia

neoplasm

increased leukemia incidence ( J:160392 )

• pIpC-treated mice develop acute B-lineage leukemia by 6 months of age unlike control mice

Allelic Composition	\Tcf3^{tm1(TCF3/HLF)Homy}/\Tcf3⁺ \Tg(Mx1-cre)1Cgn/0
Genetic Background	involves: 129P2/OlaHsd * C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^{tm1(TCF3/HLF)Homy} mutation (0 available); any Tcf3 mutation (48 available)
Tg(Mx1-cre)1Cgn mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:160392 )

N	• pIpC-treated mice have a normal lifespan

increased susceptibility to induced morbidity/mortality ( J:160392 )

• mice treated with pIpC and Moloney murine leukemia virus (MMLV) exhibit increased morbidity and mortality with all mice dying by 6 months of age unlike with similarly treated Tcf3^{tm1(TCF3/HLF)Homy} heterozygotes

hematopoietic system

hematopoietic system phenotype ( J:160392 )

N	• pIpC-treated mice exhibit no abnormalities in peripheral blood

abnormal B cell differentiation ( J:160392 )

• pIpC-treated mice exhibit an increase in B cell precursors in the bone marrow compared with similarly treated Tcf3^{tm1(TCF3/HLF)Homy} heterozygotes

increased B cell number ( J:160392 )

• pIpC-treated mice exhibit an increase in B cell precursors in the bone marrow compared with similarly treated Tcf3^{tm1(TCF3/HLF)Homy} heterozygotes

neoplasm

increased incidence of induced tumors ( J:160392 )

• mice treated with pIpC and MMLV develop only acute B-progenitor and lineage marker negative leukemias as early as 2.6 months compared with similarly treated Tcf3^{tm1(TCF3/HLF)Homy} heterozygotes that develop T cell leukemias at 4 to 6 months

homeostasis/metabolism

abnormal thrombosis ( J:160392 )

• pIpC-treated and Moloney murine leukemia virus (MMLV)-exposed mice develop microthrombi

immune system

abnormal B cell differentiation ( J:160392 )

• pIpC-treated mice exhibit an increase in B cell precursors in the bone marrow compared with similarly treated Tcf3^{tm1(TCF3/HLF)Homy} heterozygotes

increased B cell number ( J:160392 )

• pIpC-treated mice exhibit an increase in B cell precursors in the bone marrow compared with similarly treated Tcf3^{tm1(TCF3/HLF)Homy} heterozygotes

Allelic Composition	\Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Cd79a^tm1(cre)Reth/\Cd79a⁺
Genetic Background	involves: BALB/c * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd79a^tm1(cre)Reth mutation (3 available); any Cd79a mutation (26 available)
Tcf3^tm1(PBX1)Mlc mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased B cell acute lymphoblastic leukemia incidence ( J:226241 )

• mice develop acute leukemia with an incidence of 53% at 12 months of age

• leukemia cells are present in the bone marrow, spleen, lymph nodes and infiltrate multiple organs, including the CNS

• 94% of leukemias have a B cell precursor phenotype

hematopoietic system

enlarged spleen ( J:226241 )

• in leukemic mice

arrested B cell differentiation ( J:226241 )

• leukemic blasts are arrested at the pro/pre-B stage of B cell precursor differentiation

anemia ( J:226241 )

• in leukemic mice

thrombocytopenia ( J:226241 )

• in leukemic mice

decreased B cell number ( J:226241 )

• a lower percentage of B cells are seen in the peripheral blood over a 30 week period in healthy preleukemic mice

decreased immature B cell number ( J:226241 )

• decrease in immature and recirculating B cells in the bone marrow in healthy preleukemic mice

increased leukocyte cell number ( J:226241 )

• leukemic mice present with leukocytosis

immune system

enlarged spleen ( J:226241 )

• in leukemic mice

arrested B cell differentiation ( J:226241 )

• leukemic blasts are arrested at the pro/pre-B stage of B cell precursor differentiation

decreased B cell number ( J:226241 )

• a lower percentage of B cells are seen in the peripheral blood over a 30 week period in healthy preleukemic mice

decreased immature B cell number ( J:226241 )

• decrease in immature and recirculating B cells in the bone marrow in healthy preleukemic mice

increased leukocyte cell number ( J:226241 )

• leukemic mice present with leukocytosis

enlarged lymph nodes ( J:226241 )

• in leukemic mice

liver/biliary system

enlarged liver ( J:226241 )

• in leukemic mice

growth/size/body

enlarged liver ( J:226241 )

• in leukemic mice

enlarged spleen ( J:226241 )

• in leukemic mice

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
acute lymphoblastic leukemia		DOID:9952	OMIM:247640 OMIM:613065	J:226241

Allelic Composition	\Tcf3^tm1(PBX1)Mlc/\Tcf3⁺ \Tg(Mx1-cre)1Cgn/0
Genetic Background	involves: C57BL/6 * C57BL/6J * CBA/J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^tm1(PBX1)Mlc mutation (0 available); any Tcf3 mutation (48 available)
Tg(Mx1-cre)1Cgn mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased B cell acute lymphoblastic leukemia incidence ( J:226241 )

• mice develop acute leukemia with an incidence of 59% at 12 months of age

• leukemia cells are present in the bone marrow, spleen, lymph nodes and infiltrate multiple organs, including the CNS

• 94% of leukemias have a B cell precursor phenotype

hematopoietic system

enlarged spleen ( J:226241 )

• in leukemic mice

arrested B cell differentiation ( J:226241 )

• leukemic blasts are arrested at the pro/pre-B stage of B cell precursor differentiation

anemia ( J:226241 )

• in leukemic mice

thrombocytopenia ( J:226241 )

• in leukemic mice

decreased B cell number ( J:226241 )

• a lower percentage of B cells are seen in the peripheral blood over a 30 week period in healthy preleukemic mice

decreased immature B cell number ( J:226241 )

• decrease in immature and recirculating B cells in the bone marrow in healthy preleukemic mice

increased leukocyte cell number ( J:226241 )

• leukemic mice present with leukocytosis

immune system

enlarged spleen ( J:226241 )

• in leukemic mice

arrested B cell differentiation ( J:226241 )

• leukemic blasts are arrested at the pro/pre-B stage of B cell precursor differentiation

decreased B cell number ( J:226241 )

• a lower percentage of B cells are seen in the peripheral blood over a 30 week period in healthy preleukemic mice

decreased immature B cell number ( J:226241 )

• decrease in immature and recirculating B cells in the bone marrow in healthy preleukemic mice

increased leukocyte cell number ( J:226241 )

• leukemic mice present with leukocytosis

enlarged lymph nodes ( J:226241 )

• in leukemic mice

liver/biliary system

enlarged liver ( J:226241 )

• in leukemic mice

growth/size/body

enlarged liver ( J:226241 )

• in leukemic mice

enlarged spleen ( J:226241 )

• in leukemic mice

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
acute lymphoblastic leukemia		DOID:9952	OMIM:247640 OMIM:613065	J:226241

Allelic Composition	\Tcf4^tm1Zhu/\Tcf4⁺ \Tcf3^tm1Wein/\Tcf3⁺
Genetic Background	involves: 129P2/OlaHsd

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^tm1Wein mutation (0 available); any Tcf3 mutation (48 available)
Tcf4^tm1Zhu mutation (1 available); any Tcf4 mutation (61 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

postnatal lethality, incomplete penetrance ( J:43324 )

• most homozygotes died within two weeks of birth

growth/size/body

postnatal growth retardation ( J:43324 )

• evident after birth

hematopoietic system

decreased pro-B cell number ( J:43324 )

• 70% reduction in the number of pro-B cells

immune system

decreased pro-B cell number ( J:43324 )

• 70% reduction in the number of pro-B cells

Allelic Composition	\Tcf4^tm1Zhu/\Tcf4⁺ \Tcf3^tm1Zhu/\Tcf3⁺
Genetic Background	involves: 129P2/OlaHsd

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3^tm1Zhu mutation (0 available); any Tcf3 mutation (48 available)
Tcf4^tm1Zhu mutation (1 available); any Tcf4 mutation (61 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

nervous system

nervous system phenotype ( J:125313 )

N	• the pontine nucleus develops normally

Allelic Composition	\Id2^tm1Yyk/\Id2^tm1Yyk \Tcf3^tm1Cmu/\Tcf3⁺
Genetic Background	involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Id2^tm1Yyk mutation (0 available); any Id2 mutation (19 available)
Tcf3^tm1Cmu mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

decreased NK T cell number ( J:125739 )

• natural killer cell development is partially rescued in bone marrow

absent axillary lymph nodes ( J:125739 )

• absent in most mice

absent brachial lymph nodes ( J:125739 )

• absent in most mice

absent inguinal lymph nodes ( J:125739 )

• absent in most mice

hematopoietic system

decreased NK T cell number ( J:125739 )

• natural killer cell development is partially rescued in bone marrow

Allelic Composition	\Tcf12^tm1Zhu/\Tcf12⁺ \Tcf3^tm1Wein/\Tcf3⁺
Genetic Background	involves: 129S4/SvJaeSor

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf12^tm1Zhu mutation (0 available); any Tcf12 mutation (75 available)
Tcf3^tm1Wein mutation (0 available); any Tcf3 mutation (48 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

postnatal lethality, incomplete penetrance ( J:43324 )

• most homozygotes died within two weeks of birth

growth/size/body

postnatal growth retardation ( J:43324 )

• evident after birth

hematopoietic system

decreased pro-B cell number ( J:43324 )

• 70% reduction in the number of pro-B cells

immune system

decreased pro-B cell number ( J:43324 )

• 70% reduction in the number of pro-B cells

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 03/25/2025 MGI 6.24